全文获取类型
收费全文 | 1850篇 |
免费 | 141篇 |
国内免费 | 119篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 33篇 |
妇产科学 | 6篇 |
基础医学 | 82篇 |
口腔科学 | 17篇 |
临床医学 | 176篇 |
内科学 | 239篇 |
皮肤病学 | 4篇 |
神经病学 | 20篇 |
特种医学 | 26篇 |
外科学 | 73篇 |
综合类 | 517篇 |
预防医学 | 130篇 |
眼科学 | 11篇 |
药学 | 383篇 |
1篇 | |
中国医学 | 382篇 |
肿瘤学 | 9篇 |
出版年
2024年 | 17篇 |
2023年 | 22篇 |
2022年 | 53篇 |
2021年 | 60篇 |
2020年 | 53篇 |
2019年 | 48篇 |
2018年 | 39篇 |
2017年 | 46篇 |
2016年 | 65篇 |
2015年 | 68篇 |
2014年 | 116篇 |
2013年 | 146篇 |
2012年 | 132篇 |
2011年 | 128篇 |
2010年 | 104篇 |
2009年 | 81篇 |
2008年 | 96篇 |
2007年 | 96篇 |
2006年 | 112篇 |
2005年 | 92篇 |
2004年 | 95篇 |
2003年 | 67篇 |
2002年 | 39篇 |
2001年 | 60篇 |
2000年 | 55篇 |
1999年 | 41篇 |
1998年 | 30篇 |
1997年 | 36篇 |
1996年 | 17篇 |
1995年 | 14篇 |
1994年 | 14篇 |
1993年 | 7篇 |
1992年 | 11篇 |
1991年 | 8篇 |
1990年 | 5篇 |
1989年 | 6篇 |
1988年 | 4篇 |
1987年 | 5篇 |
1986年 | 2篇 |
1985年 | 2篇 |
1984年 | 4篇 |
1983年 | 1篇 |
1982年 | 2篇 |
1981年 | 3篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1974年 | 1篇 |
排序方式: 共有2110条查询结果,搜索用时 15 毫秒
51.
Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases 总被引:11,自引:0,他引:11
Angelico F Del Ben M Conti R Francioso S Feole K Maccioni D Antonini TM Alessandri C 《Journal of gastroenterology and hepatology》2003,18(5):588-594
BACKGROUND AND AIMS: The association of liver steatosis with a number of common metabolic conditions has been suggested. The aim of the present study was to evaluate the clinical features of subjects with different severities of steatosis. METHODS: The present study was performed in 282 consecutive patients with 'bright liver' at ultrasonography and in 58 subjects without steatosis. They had no history of alcohol abuse and negative tests for the presence of hepatitis B and C virus. Patients underwent clinical examination, anthropometry, laboratory tests and routine liver ultrasonography. Steatosis was graded as absent, mild, moderate and severe. RESULTS: A progressive increase in the prevalence of obesity (P < 0.001), type 2 diabetes (P < 0.001), alanine aminotransferase (ALT) elevation (P < 0.001) and hypertriglyceridemia (P < 0.001), and a decrease of hypercholesterolemia (P < 0.05) was observed from the control group to the groups with mild, moderate and severe steatosis. More than half the subjects with liver steatosis had insulin resistance metabolic syndrome. Obesity, diabetes and hypertriglyceridemia were more common by 5.3-fold, 4.0-fold, and 6.7-fold, respectively, in subjects with severe steatosis, as compared to controls. Prevalence of obesity, diabetes and hyperlipidemia was significantly higher in subjects with fatty liver and ALT elevation. CONCLUSION: Fatty liver can be considered as the hepatic consequence of common metabolic diseases. 相似文献
52.
The patency of a polytetrafluoroethylene (Gortex®) graft 9½ years after coronary artery bypass graft surgery (CABG) is demonstrated. While this material is not commonly used as a conduit because of limited success in the past, this case demonstrates that, given the right circumstances, longterm patency is possible. Since available conduits for CABG are quite often limited, viable alternatives may be lifesaving and require further evaluation. In addition to mechanical considerations such as size, length, and material, anticoagulation and strict management of hyperlipidemia may be critical. 相似文献
53.
Kvasnicka T Kvasnicka J Ceska R Vrablik M 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2003,13(4):227-231
BACKGROUND AND AIM: Elevated levels of acute phase reactants are found in patients with cardiovascular disease. It is suggested that adipose tissue is a determinant of a low level of inflammatory state in overweight persons. The aim of the study was to determine, whether combined hyperlipidemia, which is an important factor of atherosclerosis, has influence on the inflammatory response in overweight adults. METHODS AND RESULTS: Levels of soluble cell adhesion molecules sICAM-1, sE-selectin and sP-selectin, PAI-1 Ag (by Elisa test), orosomucoid (ORM) and transferrin (TRF) (by microturbidimetry) and fibrinogen (FBG) according to Clauss were examined in peripheral blood of overweight adults (n 33, body mass index 27.1 +/- 1.8 kg/m2) with combined hyperlipidemia and in equal numbers of age, sex and BMI matched non-hyperlipidemic group. Overweight adults with combined hyperlipidemia had significantly higher plasma levels of sICAM-1 (376.5 +/- 107.4 ng/mL vs 239.3 +/- 60.4 ng/mL; p < 0.001), sE-selectin (70.4 +/- 20.2 ng/mL vs 48.5 +/- 25.6 ng/mL; p = 0.005), sP-selectin (228.2 +/- 88.6 ng/mL vs 123.1 +/- 45.3 ng/mL; p < 0.001) and positive acute phase proteins ORM (0.82 +/- 0.16 g/L vs 0.64 +/- 0.20 g/L; p = 0.005), FBG (3.42 +/- 0.54 g/L vs 2.74 +/- 0.57 g/L; p = 0.037) and PAI-1 Ag (97.9 +/- 40.6 ng/mL vs 56.4 +/- 25.6 ng/mL; p < 0.05), and a decrease of negative acute phase protein TRF (2.14 +/- 0.40 g/L vs 2.77 +/- 0.45 g/L; p < 0.001) compared to the results in overweight non-hyperlipidemic controls. CONCLUSIONS: It is suggested that overweight adults have an increase of inflammatory response dependent on hyperlipidemia. It was apparent from the elevation of sE--selectin, sP--selectin and sICAM-1 and from an increase of systemic inflammatory response according to the increase of "positive" acute phase proteins (APRs) and the decrease of "negative" APR protein levels in these patients. 相似文献
54.
目的探讨降脂通脉胶囊联合藻酸双酯钠片治疗高脂血症的临床疗效。方法选择2018年3月-2019年3月在陕西省荣誉军人康复医院治疗的高脂血症患者86例,根据用药的差别分为对照组(43例)和治疗组(43例)。对照组口服藻酸双酯钠片,50mg/次,3次/d;治疗组在对照组基础上口服降脂通脉胶囊,2.0g/次,3次/d。两组患者经4周治疗。观察两组患者临床疗效,同时比较治疗前后两组患者高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、三酰甘油(TG)、胆固醇(TC)、嗜酸性粒细胞阳离子蛋白(ECP)、摄食抑制因子-1(NSF-1)、硫氧还蛋白相互作用蛋白(TXNIP)、肿瘤坏死因子-α(TFN-α)、白细胞介素-1β(IL-1β)、脂联素(ADP)、超氧化物歧化酶(SOD)、丙二醛(MDA)和谷胱甘肽过氧化物酶(GSH-Px)水平。结果治疗后,对照组临床有效率为81.40%,显著低于治疗组的97.67%,两组比较差异有统计学意义(P<0.05)。治疗后,两组患者TC、TG、LDL-C、ECP、IL-1β、TFN-α、TXNIP、NSF-1和MDA水平均显著降低(P<0.05),而HDL-C、ADP、SOD和GSH-Px水平均显著升高(P<0.05),且治疗组患者这些指标明显好于对照组(P<0.05)。结论降脂通脉胶囊联合藻酸双酯钠片治疗高脂血症可有效降低血脂指标,促进机体细胞因子和氧化应激指标的改善,具有一定的临床推广应用价值。 相似文献
55.
目的 探讨自噬对高胆固醇饮食大鼠下颌骨结构改变的影响及辛伐他汀的治疗效果。方法 将30只SD大鼠随机分为正常饮食组(NC组)10只、高胆固醇组20只;喂养24周后,高胆固醇组再随机分成两组,每组10只,一组继续喂养高胆固醇饲料(HC组),另一组在高胆固醇饲料中加入5 mg/kg辛伐他汀(HC+SIM组)。喂养32周后,取大鼠空腹血进行生化检测;处死大鼠后对下颌骨进行骨组织形态分析;实时荧光定量PCR(qRT-PCR)及免疫组织化学染色检测各组自噬相关基因Lc3及p62的mRNA和蛋白表达水平。结果 (1)3组总胆固醇和低密度脂蛋白水平总的比较,差异均有统计学意义(F值分别为21.539、16.596,均P < 0.05);其中NC组和HC+SIM组总胆固醇和低密度脂蛋白水平均低于HC组(均P < 0.05),而NC组和HC+SIM组组间比较,差异无统计学意义(P > 0.05)。(2)与NC组比较,HC组大鼠骨体积分数、骨小梁厚度、骨小梁数目明显下降,而骨小梁间隔增加,Lc3及p62 mRNA表达水平明显升高,差异均有统计学意义(均P < 0.05);与HC组比较,HC+SIM组骨体积分数、骨小梁厚度、骨小梁数目均明显升高,骨小梁间隔减小,p62 mRNA和蛋白表达水平明显下降,差异均有统计学意义(均P < 0.05);而NC组和HC+SIM组这些指标组间比较,差异均无统计学意义(均P > 0.05)。结论 自噬可能参与调控高胆固醇饮食大鼠下颌骨结构的改变,辛伐他汀能够改善高胆固醇饮食导致的大鼠下颌骨微结构的破坏 相似文献
56.
洛伐他汀对实验性家兔动脉粥样硬化形成及其相关癌基因表达作用的研究 总被引:1,自引:0,他引:1
本研究观察了洛伐他汀(lovastatin,商品名:美降之)对高胆固醇饲喂的家兔动脉粥样硬化(AS)形成及其相关癌基因表达的影响。结果显示,洛伐他汀治疗组(L组)血脂水平、AS斑块面积与主动脉内膜面积的百分比、平均最大斑块厚度和平均最大斑块与中膜比值,均较动脉粥样硬化对照组(CAS组)低(P<0.01)。CAS组原癌基因V-sis、C-fos、H-ras表达量分别是L组的2.4倍(P<0.01)、1.4倍、1.4倍(P<0.05)。提示洛伐他汀具有抗AS作用,其机制可能与降低血脂,抑制癌基因表达有关。 相似文献
57.
目的:探究氨氯地平联合阿托伐他汀在治疗高血压合并高血脂症中的临床疗效.方法:门诊治疗的高血压合并高血脂症患者200例,随机均分为观察组和对照组,观察组患者采用氨氯地平联合阿托伐他汀治疗,对照组患者采用氨氯地平进行治疗;观察两组患者治疗前后血压变化,比较治疗效果;同时比较两组患者治疗前后的低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、甘油三酯(TG)及胆固醇(TC),丙氨酸氨基转移酶(ALT)、血肌酐、血钾(K+)及血尿酸水平.结果:治疗后,观察组总有效率优于对照组,不良反应明显低于对照组(P<0.05),收缩压和舒张压较治疗前明显下降,观察组改善更明显(P<0.05);观察组患者LDL-C、TG及TC水平较治疗前下降,而HDL-C升高,这些血脂成分改变优于对照组(P<0.05);观察组治疗后,血肌酐和血尿酸水平下降明显(P<0.05),与无变化的对照组间比较,差异有统计学意义(P<0.05).结论:氨氯地平联合阿托伐他汀对高血压合并高血脂症患者的治疗效果优于单独使用氨氯地平. 相似文献
58.
59.
Naveed Khan Muhammad Shoaib Akhtar Barkat Ali Khan Valdir de Andrade Braga Adam Reich 《Archives of Medical Science》2015,11(6):1261-1271
Introduction
Numerous herbal medicines have been recommended for the treatment of different diseases. Achyranthes aspera, Linn. (Family: Amaranthaceae), popularly known as Charchitta or Pitpapra, is commonly used by traditional healers for the treatment of fever, malaria, dysentery, asthma, arterial hypertension, pneumonia, and diabetes. The root extract is well reputed for its insect molting hormonal activity. This investigation was conducted to evaluate the effects of saponins from Achyranthes aspera seeds on the serum lipid profile of albino rats fed a high cholesterol diet.Material and methods
Hypolipidemic, antioxidant and hepatoprotective activities of these saponins were tested as described previously. To determine the mechanism underlying the observed effects, serum antioxidant status was assessed according to ABTS (2,2’-azino-bis-3-ethylbenzo-thiazoline-6-sulfonic acid), superoxide dismutase and ferric ion reducing antioxidant power (FRAP) assays in saponin-treated hyperlipidemic animals. Liver enzyme levels were determined to reveal any possible hepatotoxicity.Results
Four-week oral administration of A. aspera seed saponins produced a significant (p < 0.05) decrease of total cholesterol, total triglycerides and LDL-C and a significant increase of HDL-C level in hyperlipidemic rats. Treatment with A. aspera seed saponins also showed a significant (p < 0.01) improvement of serum antioxidant status in tested animals. No significant hepatotoxicity was produced by such treatment as the serum liver enzyme activity remained unaltered.Conclusions
Saponins from A. aspera seeds possess antihyperlipidemic and antioxidant properties which might lead to improvement of serum lipid profile and blood antioxidant status. Our findings support the folkloric use of this indigenous plant in the treatment of hyperlipidemia. However, its exact mechanism of action remains to be elucidated. 相似文献60.
目的观察参七脉心通胶囊对颈动脉硬化并高脂血症患者的血脂、血清一氧化氮(NO)、血浆内皮素(ET)水平的影响,进一步探讨参七脉心通胶囊抗动脉粥样硬化的机制。方法将70例高脂血症并颈动脉硬化患者随机分为参七脉心通胶囊中药组(中药组)及阿托伐他汀西药组(西药组),每组35例,分别给予参七脉心通胶囊及阿托伐他汀口服治疗12周。于清晨空腹抽取服药前、服药后及停药2周后的静脉血,检测血总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、NO、ET水平。结果治疗12周后两组患者TC、TG、LDL及ET明显降低,血清NO及HDL水平明显升高,与治疗前相比显差异有统计学意义(P〈0.01),其中西药组优于治疗组(P〈0.05);停药2周后西药组所有患者TC、TG和LDL水平较治疗后升高,NO水平明显降低,与服药前无明显差异(P>0.05);而ET水平则明显回升,甚至高于服药前水平(P〈0.05)。在中药组却未出现这种趋势。结论参七脉心通胶囊对高脂血症并颈动脉硬化患者的血管内皮功能有明显保护作用,从而防治动脉硬化的进一步发展。 相似文献